Metlife Stock Price To Earnings To Growth
| METB34 Stock | BRL 495.39 0.00 0.00% |
MetLife fundamentals help investors to digest information that contributes to MetLife's financial success or failures. It also enables traders to predict the movement of MetLife Stock. The fundamental analysis module provides a way to measure MetLife's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MetLife stock.
MetLife |
MetLife Company Price To Earnings To Growth Analysis
MetLife's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current MetLife Price To Earnings To Growth | 5.21 X |
Most of MetLife's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MetLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, MetLife has a Price To Earnings To Growth of 5.2053 times. This is 274.67% lower than that of the Financial Services sector and significantly higher than that of the Insurance—Life industry. The price to earnings to growth for all Brazil stocks is 6.45% lower than that of the firm.
MetLife Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MetLife's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MetLife could also be used in its relative valuation, which is a method of valuing MetLife by comparing valuation metrics of similar companies.MetLife is rated below average in price to earnings to growth category among its peers.
MetLife Fundamentals
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 413.71 B | |||
| Shares Outstanding | 779.1 M | |||
| Price To Earning | 60.42 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 4.14 X | |||
| Revenue | 69.9 B | |||
| Gross Profit | 15.56 B | |||
| EBITDA | 4.04 B | |||
| Net Income | 2.54 B | |||
| Cash And Equivalents | 35.84 B | |||
| Cash Per Share | 41.83 X | |||
| Total Debt | 17.8 B | |||
| Debt To Equity | 1.58 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 34.71 X | |||
| Cash Flow From Operations | 12.6 B | |||
| Earnings Per Share | 15.40 X | |||
| Price To Earnings To Growth | 5.21 X | |||
| Number Of Employees | 49 | |||
| Beta | 1.08 | |||
| Market Capitalization | 294.41 B | |||
| Total Asset | 666.61 B | |||
| Z Score | 9.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 3.58 % | |||
| Net Asset | 666.61 B | |||
| Last Dividend Paid | 1.98 |
About MetLife Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MetLife's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetLife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetLife based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in MetLife Stock
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade MetLife Stock refer to our How to Trade MetLife Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.